Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Adaptation of Individual Meaning-Centered Psychotherapy for Chinese Immigrant Cancer Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Memorial Sloan-Kettering Cancer Center
Sponsor:
Collaborators:
Queens Cancer Center of Queens Hospital
Charles B. Wang Community Health Center (CBWCHC)
ACS Asian Initiatives
New York Coalition for Asian American Mental Health (NYCAAMH)
New York Hospital Queens
Chinese Christian Herald Crusades (CCHC)
Cheung and Kan Medical Group, PLLC
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT02112188
First received: April 7, 2014
Last updated: October 22, 2014
Last verified: October 2014
  Purpose

The purpose of the study is to modify a type of counseling called "Individual Meaning Centered Psychotherapy" to meet the needs of Chinese cancer patients. Many cancer patients use counseling or other resources to help cope with the emotional burden of their illnesses. Counseling often helps them cope with cancer by giving them a place to express their feelings. "Meaning-Centered" counseling aims to teach cancer patients how to maintain or even increase a sense of meaning and purpose in their lives, despite cancer.


Condition Intervention
Stage IV Cancer
Behavioral: In-depth Patient Interviews
Behavioral: Adaptation of IMCP for Chinese Immigrant Cancer Patients

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Adaptation of Individual Meaning-Centered Psychotherapy for Chinese

Resource links provided by NLM:


Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • adapt the Individual Meaning-Centered Psychotherapy (IMCP) [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    through formative research, including in-depth interviews, to be culturally and linguistically tailored for Chinese immigrant cancer patients (IMCP-Ch), using the Ecological Validity Model (EVM) of Bernal et al. (3) and the Cultural Adaptation Process (CAP) model of Domenech-Rodriquez and Weiling (1). This addresses existential issues using didactics and experiential exercises and has demonstrated efficacy in reducing existential suffering and improving psychosocial functioning among advanced cancer patients.


Estimated Enrollment: 20
Study Start Date: April 2014
Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Chinese patients with advanced cancer
This is a study to adapt the IMCP intervention to be culturally and linguistically tailored for Chinese cancer patients. This study will be carried out in two phases: 1) formative research and 2) adaptation. For this application we will continue the formative research (phase 1) by conducting 20 to 30 indepth interviews with Chinese immigrants with advanced cancer to inform the adaptation of the intervention. Results of the patient in-depth interviews will inform how to adapt the IMCP process and session themes to reflect the needs of the community. In the adaptation phase (phase 2) the Breitbart IMCP research team (including Drs. Breitbart, Lichtenthal, and Applebaum), Drs. Leng, Gany, and Ms. Huang will discuss a priori adaptations to the intervention. Potential changes to the process and content will be discussed. Adaptations will be incorporated in a modified IMCP-Ch treatment manual, therapist checklist/outline and Treatment Integrity Coding Manual.
Behavioral: In-depth Patient Interviews Behavioral: Adaptation of IMCP for Chinese Immigrant Cancer Patients

  Eligibility

Ages Eligible for Study:   21 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Participants will be recruited from MSKCC, QCC, CCHC, ACS Asian Initiatives, CBWCHC, NYHQ and NYCAAMH and the Cheung and Kan Medical Group,.

Criteria

Inclusion Criteria:

  • Non-US born;
  • Of Chinese descent;
  • Age 21 years through 80 years;
  • Language spoken: Mandarin and/or English
  • Diagnosis of Stage IV cancer (any type).

Exclusion Criteria:

  • Presence of cognitive impairment disorder (e.g., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection. The Chinese version of the Mini Mental State Examination (MMSE) (46) will be used as a cognitive screening tool. Patients with MMSE scores below 20 will be excluded. For English speaking patients we will use the English version of the MMSE.
  • Has a household member who has already participated (or agreed to participate).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02112188

Contacts
Contact: Jennifer Leng, MD, MPH 646-888-4243
Contact: Francesca Gany, MD, MS 646-888-4240

Locations
United States, New York
Queens Hospital Center Not yet recruiting
Jamaica, New York, United States, 11432
Contact: Margaret Kemeny, MD         
Principal Investigator: Margaret Kemeny, MD         
Memorial Sloan Kettering Cancer Center Recruiting
New York, New York, United States, 10065
Contact: Jennifer Leng, MD,MPH    646-888-4243      
Contact: Francesca Gany, MD,MS    646-888-4240      
Principal Investigator: Jennifer Leng, MD, MPH         
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Queens Cancer Center of Queens Hospital
Charles B. Wang Community Health Center (CBWCHC)
ACS Asian Initiatives
New York Coalition for Asian American Mental Health (NYCAAMH)
New York Hospital Queens
Chinese Christian Herald Crusades (CCHC)
Cheung and Kan Medical Group, PLLC
Investigators
Principal Investigator: Jennifer Leng, MD, MPH Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT02112188     History of Changes
Other Study ID Numbers: 14-076
Study First Received: April 7, 2014
Last Updated: October 22, 2014
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on November 25, 2014